Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > Good post on Yahoo ! Thx John.
View:
Post by cool888 on Jul 17, 2021 9:14am

Good post on Yahoo ! Thx John.

Good week for RVVTF as our future looks exciting given the recent announcements. One thing I’ve been watching over the past few months other than the strong fundamentals is what the insiders have been doing ?
Remember Revive’s Board of Director’s recently granted themselves stock options in lieu of increased salaries or cash bonuses. Plus I read a recent Yahoo post mentioning MF also received another 11m shares..? Also = Not “1” insider has sold “1” RVVTF share over the past 17 months since my first purchase. In fact Michael Frank was buying cheap shares on the open market a few months back in a show of support for his company. Interesting timing per these options as my thoughts are = Michael Frank is building Revive to eventually be acquired. Which would be good news for both insiders & shareholders for 2 reasons:
1.) How else would MF / BofD be able to liquidate stock per the required SEC filing without spooking the market. Inevitably news of insiders selling regardless of personal reasons / financial needs may initiate a sell-off thus hurting everyone’s financial position.
2.) A public company in “growth mode” usually commands a higher buyout price vs current SP market cap.
Posted on Revive’s website about the BofD / M Frank…
Mr. Michael Frank is the Chairman of the Board and CEO of Revive. Mr. Frank has a strong background in operations, business development, M&A and the capital markets. Mr. Frank is currently the President of Mifran Consulting, providing advisory services to emerging technology companies in a number of key verticals. In the past, Mr. Frank has served as the CEO and Director of Sprylogics International and the Internet of Things Inc., as well as holding senior management positions at Ernst & Young, Data General, and NCR. Mr. Frank has had successful exits in the technology sector including one to Intuit Corporation, and has been instrumental in advising several early stage software companies including a number in the cannabis sector over the last few years. Additionally, Mr. Frank has consulted to Revive’s senior management team on various strategic initiatives…
Michael Frank’s Bio + Business Experience basically says BUYOUT…That’s his history & what he’s good at…Key Words = Business Development – M&A – Advisory Services - Successful Exits… Formulate your own opinion but mine says Revive will eventually be bought out…With our recent PARTNERSHIP w “SUPRIYA LIFESCIENCE LTD” who currently supplies pharmaceuticals to 78 countries with a footprint in another 27 = Guarantee Pfizer – J&J & the other Greedy Pharma’s have caught wind of RVVTF. Lastly although RVVTF has graduated to the QTCQB that doesn’t automatically mean we’re being treated well by new friendly market makers = We’re not…As RVVTF institutional base grows (which it will as word gets out) so will the stock price. Stay Patient.
Comment by slumdawg on Jul 18, 2021 2:15am
Thank you for the analytical profile post. I've never had a company I hold shares in bought out. What effect would that have on the current share price? Would you expext a large offerring that would maybe increase the sp to say 5x, 10x, or would it just be like a 10, 20, or maybe 30 cent increase? I know that would depend on the offer, but what would be your expectation ----- if all goes very ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities